Gaxos.Ai Inc. (GXAI) Stock Price & Analysis
Gaxos.Ai Inc. (GXAI) fell 7.03% to USD 1.19 as of June 10, 2026 at 01:08 UTC, according to Nexqual real-time market data.
GXAI last closed at USD 1.28; the session ranged USD 1.19–1.3 on volume of 881,045 shares. Market capitalization is $12.16M, with a 52-week range of USD 1.02–2.96 (NCM). Source: Nexqual, June 10, 2026 at 01:08 UTC.
Key Statistics (as of June 10, 2026 at 01:08 UTC)
| Price | USD 1.19 |
|---|---|
| Change | ▼ 7.03% (down) |
| Previous Close | USD 1.28 |
| Open | USD 1.28 |
| Day Range | USD 1.19 – 1.3 |
| 52-Week Range | USD 1.02 – 2.96 |
| Volume | 881,045 shares |
| Market Cap | $12.16M |
| Exchange | NCM |
Technical Analysis (GXAI)
Nexqual's technical model rates GXAI "SELL" based on 2 bullish and 4 bearish signals across 124 daily candles, as of June 10, 2026 at 01:08 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 44.56 (neutral) |
| vs SMA50 | Below (USD 1.24) |
| MACD | 0.02 (positive) |
Analyst Ratings (GXAI)
Wall Street analysts rate GXAI "None" based on 1 analysts, with a mean price target of USD 2.7 (range USD 2.7–2.7), per Nexqual as of June 10, 2026 at 01:08 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 2.7 |
| High Target | USD 2.7 |
| Low Target | USD 2.7 |
| Buy / Hold / Sell | 0 / 0 / 0 |
Earnings (GXAI)
| Revenue Estimate | $1.75M |
|---|
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD -0.25 vs est -0.2 ▼ miss |
| 2025-12-31 | USD -0.13 vs est -0.16 ▲ beat |
Source: Nexqual, June 10, 2026 at 01:08 UTC.
Financials & Fundamentals (GXAI)
| Total Revenue | $3.72M |
|---|---|
| Revenue Growth (YoY) | +7524.20% |
| Gross Margin | +100.00% |
| Operating Margin | -140.77% |
| Profit Margin | -131.27% |
| ROE | -35.81% |
| Current Ratio | 21.35 |
| Total Cash | $11.82M |
| Total Debt | $0 |
| Free Cash Flow | $-3.48M |
Source: Nexqual, June 10, 2026 at 01:08 UTC.
Financial Health Score (GXAI)
Nexqual rates Gaxos.Ai Inc.'s overall financial health "Weak" across five dimensions, as of June 10, 2026 at 01:08 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $12M cash, no debt |
| Cash Flow | Weak — FCF negative: -$3M, burning cash |
| Efficiency | Critical — ROE -36%, ROA -23.8% |
Ownership (GXAI)
| Insider Ownership | +2.18% |
|---|---|
| Institutional Ownership | +6.82% |
| Shares Outstanding | 10.22M |
| Float | 6.54M |
| Short % of Float | +1.58% |
Source: Nexqual, June 10, 2026 at 01:08 UTC.
Leadership (GXAI)
Gaxos.Ai Inc. is led by Vadim Mats (age 41), Chairman, CEO & Secretary, per Nexqual as of June 10, 2026 at 01:08 UTC.
| Chairman, CEO & Secretary | Vadim Mats (age 41) |
|---|---|
| Chief Financial Officer | Steven A. Shorr (age 56) |
Major Backers & Investors (GXAI)
Notable institutional backers of Gaxos.Ai Inc. include Fidelity, Jane Street Group, LLC, Raymond James Financial, Inc., according to Nexqual as of June 10, 2026 at 01:08 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Fidelity | 1.49% |
| Jane Street Group, LLC | 0.42% |
| Raymond James Financial, Inc. | 0.29% |
| Virtu Financial LLC | 0.21% |
| Two Sigma Investments, LP | 0.19% |
| Xtx Topco Ltd | 0.16% |
| Allworth Financial LP | 0.14% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 2.33% |
| Geode Capital | 1.71% |
Source: Nexqual, June 10, 2026 at 01:08 UTC.
From Gaxos.Ai Inc.'s Latest SEC 10-K Filing (filed 2026-03-17)
Key Strengths & Strategy (as disclosed to the SEC)
- Art-Gen combines state-of-the-art AI models from industry leaders including Google, Stability AI, and PixVerse with Gaxos' proprietary enhancements to deliver unmatched creative speed, detail, and flexibility.
Partnerships
- On October 10, 2024, the Company, RNK Health and Nekwellness entered into an operating agreement with respect to the regulation and management of the affairs of RNK Health and, as of such date, the Company owns a 70% membership interest in RNK Health and Nekwellness owns a 30% membership interest in RNK Health.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CXAI | CXApp Inc. | USD 0.22 | ▼ 9.23% |
| BNAI | Brand Engagement Network Inc. | USD 19.18 | ▼ 13.49% |
| JTAI | Jet.AI Inc. | USD 7.81 | ▲ 2.76% |
| VCIG | VCI Global Limited | USD 6.04 | ▼ 14.81% |
| RENX | RenX Enterprises Corp. | USD 1.7 | ▼ 0.58% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 01:08 UTC. This page is informational and not investment advice.